Cargando…
Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites
BACKGROUND: In England, ‘fast-track’ (also known as ‘two-week wait’) general practitioner referrals for suspected cancer in symptomatic patients are used to shorten diagnostic intervals and are supported by clinical guidelines. However, the use of the fast-track pathway may vary for different patien...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765227/ https://www.ncbi.nlm.nih.gov/pubmed/29182609 http://dx.doi.org/10.1038/bjc.2017.381 |
_version_ | 1783292191433555968 |
---|---|
author | Zhou, Y Mendonca, S C Abel, G A Hamilton, W Walter, F M Johnson, S Shelton, J Elliss-Brookes, L McPhail, S Lyratzopoulos, G |
author_facet | Zhou, Y Mendonca, S C Abel, G A Hamilton, W Walter, F M Johnson, S Shelton, J Elliss-Brookes, L McPhail, S Lyratzopoulos, G |
author_sort | Zhou, Y |
collection | PubMed |
description | BACKGROUND: In England, ‘fast-track’ (also known as ‘two-week wait’) general practitioner referrals for suspected cancer in symptomatic patients are used to shorten diagnostic intervals and are supported by clinical guidelines. However, the use of the fast-track pathway may vary for different patient groups. METHODS: We examined data from 669 220 patients with 35 cancers diagnosed in 2006–2010 following either fast-track or ‘routine’ primary-to-secondary care referrals using ‘Routes to Diagnosis’ data. We estimated the proportion of fast-track referrals by sociodemographic characteristic and cancer site and used logistic regression to estimate respective crude and adjusted odds ratios. We additionally explored whether sociodemographic associations varied by cancer. RESULTS: There were large variations in the odds of fast-track referral by cancer (P<0.001). Patients with testicular and breast cancer were most likely to have been diagnosed after a fast-track referral (adjusted odds ratios 2.73 and 2.35, respectively, using rectal cancer as reference); whereas patients with brain cancer and leukaemias least likely (adjusted odds ratios 0.05 and 0.09, respectively, for brain cancer and acute myeloid leukaemia). There were sex, age and deprivation differences in the odds of fast-track referral (P<0.013) that varied in their size and direction for patients with different cancers (P<0.001). For example, fast-track referrals were least likely in younger women with endometrial cancer and in older men with testicular cancer. CONCLUSIONS: Fast-track referrals are less likely for cancers characterised by nonspecific presenting symptoms and patients belonging to low cancer incidence demographic groups. Interventions beyond clinical guidelines for ‘alarm’ symptoms are needed to improve diagnostic timeliness. |
format | Online Article Text |
id | pubmed-5765227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57652272018-01-16 Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites Zhou, Y Mendonca, S C Abel, G A Hamilton, W Walter, F M Johnson, S Shelton, J Elliss-Brookes, L McPhail, S Lyratzopoulos, G Br J Cancer Clinical Study BACKGROUND: In England, ‘fast-track’ (also known as ‘two-week wait’) general practitioner referrals for suspected cancer in symptomatic patients are used to shorten diagnostic intervals and are supported by clinical guidelines. However, the use of the fast-track pathway may vary for different patient groups. METHODS: We examined data from 669 220 patients with 35 cancers diagnosed in 2006–2010 following either fast-track or ‘routine’ primary-to-secondary care referrals using ‘Routes to Diagnosis’ data. We estimated the proportion of fast-track referrals by sociodemographic characteristic and cancer site and used logistic regression to estimate respective crude and adjusted odds ratios. We additionally explored whether sociodemographic associations varied by cancer. RESULTS: There were large variations in the odds of fast-track referral by cancer (P<0.001). Patients with testicular and breast cancer were most likely to have been diagnosed after a fast-track referral (adjusted odds ratios 2.73 and 2.35, respectively, using rectal cancer as reference); whereas patients with brain cancer and leukaemias least likely (adjusted odds ratios 0.05 and 0.09, respectively, for brain cancer and acute myeloid leukaemia). There were sex, age and deprivation differences in the odds of fast-track referral (P<0.013) that varied in their size and direction for patients with different cancers (P<0.001). For example, fast-track referrals were least likely in younger women with endometrial cancer and in older men with testicular cancer. CONCLUSIONS: Fast-track referrals are less likely for cancers characterised by nonspecific presenting symptoms and patients belonging to low cancer incidence demographic groups. Interventions beyond clinical guidelines for ‘alarm’ symptoms are needed to improve diagnostic timeliness. Nature Publishing Group 2018-01 2017-11-28 /pmc/articles/PMC5765227/ /pubmed/29182609 http://dx.doi.org/10.1038/bjc.2017.381 Text en Copyright © 2018 The Author(s) http://creativecommons.org/licenses/by/4.0/ This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Clinical Study Zhou, Y Mendonca, S C Abel, G A Hamilton, W Walter, F M Johnson, S Shelton, J Elliss-Brookes, L McPhail, S Lyratzopoulos, G Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites |
title | Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites |
title_full | Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites |
title_fullStr | Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites |
title_full_unstemmed | Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites |
title_short | Variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites |
title_sort | variation in ‘fast-track’ referrals for suspected cancer by patient characteristic and cancer diagnosis: evidence from 670 000 patients with cancers of 35 different sites |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765227/ https://www.ncbi.nlm.nih.gov/pubmed/29182609 http://dx.doi.org/10.1038/bjc.2017.381 |
work_keys_str_mv | AT zhouy variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites AT mendoncasc variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites AT abelga variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites AT hamiltonw variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites AT walterfm variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites AT johnsons variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites AT sheltonj variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites AT ellissbrookesl variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites AT mcphails variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites AT lyratzopoulosg variationinfasttrackreferralsforsuspectedcancerbypatientcharacteristicandcancerdiagnosisevidencefrom670000patientswithcancersof35differentsites |